Full Text
Cost Of Erythropoietin Use In The Early Access Program Of Telaprevir For The Treatment Of Metavir F3-F4 Patients With Genotype 1 Hcv In Brazil

Abstract

Authors

A.D. Morais L.A. Magno C.V. Nogueira

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×